Epstein-barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas

Journal of General Virology

Volumn 94, Issue PART 5, 2013, Pages 1127-1133

  Incrocci, Ryan ^a   McCormack, Molly ^b   Swanson Mungerson, Michelle ^a  

^a MIDWESTERN UNIVERSITY   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; PHOSPHATIDYLINOSITOL 3 KINASE; VIRUS PROTEIN;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER SURVIVAL; CELL LINE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84876237890     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.049221-0     Document Type: Article

References (43)

1. Babcock, G. J., Decker, L. L., Volk, M. & Thorley-Lawson, D. A. (1998). EBV persistence in memory B cells in vivo. Immunity 9, 395-404.
2. Babcock, G. J., Hochberg, D. & Thorley-Lawson, A. D. (2000). The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13, 497-506.
3. Babcock, G. J., Miyashita-Lin, E. M. & Thorley-Lawson, D. A. (2001). Detection of EBV infection at the single-cell level. Precise quantitation of virus-infected cells in vivo. Methods Mol Biol 174, 103-110.
4. Banchereau, J., Blanchard, D., Brière, F., Galizzi, J. P., Garrone, P., Hermann, P., Lebecque, S. & Rousset, F. (1993). Role of cytokines in human B lymphocyte growth and differentiation. Nouv Rev Fr Hematol 35, 61-66.
5. Beatty, P. R., Krams, S. M. & Martinez, O. M. (1997). Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J Immunol 158, 4045-4051.
6. Bechtel, D., Kurth, J., Unkel, C. & Küppers, R. (2005). Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas. Blood 106, 4345-4350.
7. Bell, A. I., Groves, K., Kelly, G. L., Croom-Carter, D., Hui, E., Chan, A. T. & Rickinson, A. B. (2006). Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J Gen Virol 87, 2885-2890.
8. Brennan, P. (2001). Signalling events regulating lymphoid growth and survival. Semin Cancer Biol 11, 415-421.
9. Bultema, R., Longnecker, R. & Swanson-Mungerson, M. (2009). Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis. Oncogene 28, 1471-1476.
10. Burdin, N., Van Kooten, C., Galibert, L., Abrams, J. S., Wijdenes, J., Banchereau, J. & Rousset, F. (1995). Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol 154, 2533-2544.
11. Caldwell, R. G., Wilson, J. B., Anderson, S. J. & Longnecker, R. (1998). Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405-411.
12. Cortes, J. & Kurzrock, R. (1997). Interleukin-10 in non-Hodgkin's lymphoma. Leuk Lymphoma 26, 251-259.
13. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G. & de Vries, J. E. (1991). Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174, 1209-1220.
14. Decker, L. L., Klaman, L. D. & Thorley-Lawson, D. A. (1996). Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J Virol 70, 3286-3289.
15. Enk, A. H. & Katz, S. I. (1992). Identification and induction of keratinocyte-derived IL-10. J Immunol 149, 92-95.
16. Fukuda, M. & Longnecker, R. (2004). Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway. J Virol 78, 1697-1705.
17. Hatton, O., Phillips, L. K., Vaysberg, M., Hurwich, J., Krams, S. M. & Martinez, O. M. (2011). Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+(EBV+) B cell lymphomas. J Biol Chem 286, 37368-37378.
18. Hochberg, D., Middeldorp, J. M., Catalina, M., Sullivan, J. L., Luzuriaga, K. & Thorley-Lawson, D. A. (2004). Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A 101, 239-244.
19. Ikeda, M. & Longnecker, R. (2007). Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability. Virology 360, 461-468.
20. Ikeda, A., Merchant, M., Lev, L., Longnecker, R. & Ikeda, M. (2004). Latent membrane protein 2A, a viral B cell receptor homologue, induces CD5+ B-1 cell development. J Immunol 172, 5329-5337.
21. Jochum, S., Moosmann, A., Lang, S., Hammerschmidt, W. & Zeidler, R. (2012). The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination. PLoS Pathog 8, e1002704.
22. Khatri, V. P. & Caligiuri, M. A. (1998). A review of the association between interleukin-10 and human B-cell malignancies. Cancer Immunol Immunother 46, 239-244.
23. Konforte, D. & Paige, C. J. (2009). Interleukin-21 regulates expression of the immediate-early lytic cycle genes and proteins in Epstein-Barr virus infected B cells. Virus Res 144, 339-343.
24. Lambert, S. L. & Martinez, O. M. (2007). Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10. J Immunol 179, 8225-8234.
25. Liu, Y., de Waal Malefyt, R., Briere, F., Parham, C., Bridon, J. M., Banchereau, J., Moore, K. W. & Xu, J. (1997). The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J Immunol 158, 604-613.
26. Longnecker, R., Miller, C. L., Miao, X. Q., Marchini, A. & Kieff, E. (1992). The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential. J Virol 66, 6461-6469.
27. Mancao, C. & Hammerschmidt, W. (2007). Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for Bcell survival. Blood 110, 3715-3721.
28. Miller, C. L., Longnecker, R. & Kieff, E. (1993). Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J Virol 67, 3087-3094.
29. Mizoguchi, A. & Bhan, A. K. (2006). A case for regulatory B cells. J Immunol 176, 705-710.
30. Niedobitek, G., Agathanggelou, A., Herbst, H., Whitehead, L., Wright, D. H. & Young, L. S. (1997). Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J Pathol 182, 151-159.
31. O'Garra, A. & Howard, M. (1992). Cytokines and Ly-1 (B1) B cells. Int Rev Immunol 8, 219-234.
32. O'Garra, A. & Vieira, P. (2007). T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 7, 425-428.
33. O'Garra, A., Stapleton, G., Dhar, V., Pearce, M., Schumacher, J., Rugo, H., Barbis, D., Stall, A., Cupp, J. & other authors (1990). Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 2, 821-832.
34. Portis, T. & Longnecker, R. (2004). Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Oncogene 23, 8619-8628.
35. Rochford, R., Miller, C. L., Cannon, M. J., Izumi, K. M., Kieff, E. & Longnecker, R. (1997). In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2). Arch Virol 142, 707-720.
36. Rode, H. J., Bugert, J. J., Handermann, M., Schnitzler, P., Kehm, R., Janssen, W., Delius, H. & Darai, G. (1994). Molecular characterization and determination of the coding capacity of the genome of equine herpesvirus type 2 between the genome coordinates 0.235 and 0.258 (the EcoRI DNA fragment N; 4.2 kbp). Virus Genes 9, 61-75.
37. Samanta, M., Iwakiri, D. & Takada, K. (2008). Epstein-Barr virusencoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 27, 4150-4160.
38. Saraiva, M. & O'Garra, A. (2010). The regulation of IL-10 production by immune cells. Nat Rev Immunol 10, 170-181.
39. Swanson-Mungerson, M., Bultema, R. & Longnecker, R. (2006). Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro. J Virol 80, 6764-6770.
40. Swanson-Mungerson, M., Bultema, R. & Longnecker, R. (2010). Epstein-Barr virus LMP2A imposes sensitivity to apoptosis. J Gen Virol 91, 2197-2202.
41. Tsai, S. C., Lin, S. J., Chen, P. W., Luo, W. Y., Yeh, T. H., Wang, H. W., Chen, C. J. & Tsai, C. H. (2009). EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBVinfected B cells and lymphoblastoid cell lines. Blood 114, 109-118.
42. Vockerodt, M., Haier, B., Buttgereit, P., Tesch, H. & Kube, D. (2001). The Epstein-Barr virus latent membrane protein 1 induces interleukin- 10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway. Virology 280, 183-198.
43. Yoon, S. I., Jones, B. C., Logsdon, N. J., Harris, B. D., Kuruganti, S. & Walter, M. R. (2012). Epstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties. J Biol Chem 287, 26586-26595.